Telehealth companies lobby on prescribing as DEA mulls rule change

Telehealth companies are attempting to influence the Drug Enforcement Agency on remote prescribing of controlled substances. 

In May, the DEA 

that allow telehealth companies to remotely prescribe certain controlled substances without an in-person visit until this November. The DEA’s original proposed rule in February would have allowed Schedule III-V substances like codeine, Xanax and Ambien to be prescribed over…